ALN-CC5
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALN-CC5, covering 2020-03-30 to 2020-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH [Phase 1, Phase 2]